Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: Implications in cardiovascular risk factors management and primary prevention of cardiovascular disease
Explore this paper's citation graph
Summary
It was found that more than half of the patients were reclassified to a higher cardiovascular risk category with important clinical implications on the correct management of their cardiovascular risk factors and primary prevention of cardiovascular disease, as a considerable proportion of patients with hypertension, hypercholesterolemia and coronary heart disease equivalent risk were not being correctly managed.
- Type
- article
- Published
- 2013-11-01
- Cited by
- 27
- References
- 15
- OpenAlex
- https://openalex.org/W24128349
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:32259123
Keywords
Geology
References
- Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the United Kingdom
- Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
- Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis.
- Aspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directions.
- Usefulness of the framingham risk score in patients with chronic psoriasis.
- Risk of myocardial infarction in patients with psoriasis.
- Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
- Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events
- Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.
- Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
- The Impact of Psoriasis on Ten-Year Framingham Risk
- Prediction of coronary heart disease using risk factor categories.
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- Mechanisms of Disease: Psoriasis.
- Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Cited by
- Recognizing and managing comorbidities in psoriatic arthritis
- Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future Perspectives
- Früherkennung der Komorbidität bei Psoriasis: Konsensusempfehlungen der Nationalen Konferenz zur Versorgung der Psoriasis
- Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis
- Comorbidities in Psoriatic Arthritis.
- Risk of thromboembolism and fatal stroke in patients with psoriasis and nonvalvular atrial fibrillation: a Danish nationwide cohort study
- On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study
- Coronary artery events in Thai patients with psoriasis using Framingham and Ramathibodi–Electricity Generating Authority of Thailand risk scores
- Psoriasis: Behind the scenes
- Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritis
- Prediction of 30‐year cardiovascular disease risk in psoriatic population
- The Value of Nursing Risk Assessment and Prevention in Cardiology
- Cardiovascular Risk in Psoriasis: Current State of the Art.
- Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa
- Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
- Enthesitis and joint erosions are disease traits associated with cardiovascular risk in psoriatic arthritis
- Bee products consumption and cardiovascular diseases risk factors: a systematic review of interventional studies
- Underperformance of clinical risk scores in identifying imaging-based high cardiovascular risk in psoriasis: results from two observational cohorts.
- microRNAs involved in psoriasis and cardiovascular diseases
- Updates in the Impact of Chronic Systemic Inflammation on Vascular Inflammation by Positron Emission Tomography (PET)
Related papers
No related papers recorded.